ArticleEuropean urologyPublished
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study
14 of 120 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, University of Pennsylvania, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Article
- Venue
- European urology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Prostatic Neoplasms; Genetic Predisposition to Disease; Kallikreins; Prostate-Specific Antigen; BRCA1 Protein; BRCA2 Protein; Neoplasm Staging; Incidence; Heterozygote; Germ-Line Mutation; Genes, BRCA1
- PubMed ID
- 41714267
- PubMed Central ID
- PMC13401181
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked